- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Fischer Medical Ventures Limited has submitted its Annual Secretarial Compliance Report for the financial year ended 31 March 2025. The report confirms overall compliance with applicable SEBI and stock exchange requirements, except for a delayed disclosure related to an application for promoter/public status reclassification, which the company has addressed by strengthening internal controls. The company withdrew its previously approved preferential equity share issue. All key governance aspects, including policy adoption, related party transactions, insider trading compliance, and record maintenance, meet required standards. No penalties or actions were taken against the company or its directors during the period.